The challenges and potential solutions described in the Montreal model for ketamine therapy may hold relevance for the upcoming transition of drugs like psilocybin from clinical trials to clinical care.

Authors

• Person: Not available Organization: Frontiers in Psychiatry
  The Montreal model: an integrative biomedical-psychedelic ...

Sources

• The Montreal model: an integrative biomedical-psychedelic ... www.frontiersin.org Frontiers in Psychiatry via serper

Referenced by nodes (3)

• psilocybin concept
• Montreal model concept
• ketamine-assisted psychotherapy concept